(Q44341326)

2 December 2017

title

Decreased homovanillic acid concentrations in cerebrospinal fluid in children without a known defect in dopamine metabolism (English)

1 reference

2 December 2017

0 references

0 references

3

1 reference

2 December 2017

Van Der Heyden JC

1

1 reference

2 December 2017

Rotteveel JJ

series ordinal

2

1 reference

2 December 2017

publication date

1 January 2003

1 reference

European Journal of Paediatric Neurology

2 December 2017

published in

1 reference

2 December 2017

volume

7

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

31-37

1 reference

A review of biochemical and molecular genetic aspects of tyrosine hydroxylase deficiency including a novel mutation (291delC).

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

Reproducibility of monoamine metabolite measurements in human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18–88 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

Concentration gradients for HVA, 5-HIAA, ascorbic acid, and uric acid in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

Aromatic L-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

Cerebrospinal fluid and serum levels of dopa, catechols, and monoamine metabolites in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of children with febrile convulsions

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

Diminished ventricular fluid dopamine metabolites in adult-onset dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

Rapid-onset dystonia-parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. Part 1. Background variables

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. Part 2. Psychopathological symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

Correlation between high-performance liquid chromatography and automated fluorimetric methods for the determination of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindoleacetic acid in nervous tissue and cerebrospinal flu

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

Proton magnetic resonance spectroscopic imaging in the clinical evaluation of patients with Niemann-Pick type C disease

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

[18F]fluorodopa PET shows striatal dopaminergic dysfunction in juvenile neuronal ceroid lipofuscinosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

Homovanillic acid and 5-hydroxyindoleacetic acid in lumbar cerebrospinal fluid in children with afebrile and febrile convulsions

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

A study of monoamine metabolism in human epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3798%2802%2900137-X

7 January 2021

10.1016/S1090-3798(02)00137-X

Identifiers

DOI

1 reference

2 December 2017

1 reference